Skip navigation

ATTORNEYS AT LAW

Cases
Who We Are
- Scott+Scott LLP is a nationally recognized law firm headquartered in Connecticut with offices in New York City, Ohio and California. The firm represents individual as well as institutional investors who have suffered from corporate stock fraud. Scott+Scott has participated in recovering billions of dollars and achieved precedent-setting reforms in corporate governance on behalf of its clients. In addition to being involved in complex shareholder securities and corporate governance actions, Scott+Scott also has a significant national practice in antitrust, ERISA, consumer, civil rights and human rights litigation. Through its efforts, Scott+Scott promotes corporate social responsibility… read more
Our Practice
- Securities Fraud + Corporate Governance +
  
  Scott + Scott is a nationally recognized law firm that recovers money for individual and institutional… read more
- Antitrust +
  
  The firm is actively involved in litigating many complex antitrust cases throughout the United States… read more
- Consumer Rights +
  
  Scott + Scott regularly represents aggrieved consumers in a variety of class action cases… read more
- Employee Benefits (ERISA) +
  
  Scott + Scott actively litigates complex class actions across the United States on behalf of corporate employees… read more
Attorneys
- The attorneys in our firm are a diverse and accomplished group, with degrees from a variety of law schools, including Yale University, University of Wisconsin, University of Connecticut, University of Kentucky, New York University, University of Chicago, Temple University, George Washington University, University of Washington, University of San Diego, University of California, Ohio State University, Boston College and Boston University. Many graduated with distinction and were members and editors of their respective schools' law reviews, moot courts or honor fraternities. Several have served federal or state judicial clerkships. Others hold graduate degrees in law, tax or other disciplines… read more
Pressbox
- Scott+Scott LLP maintains a regular media presence, publishing informative articles on a regular basis, as well as appearing frequently in the news… read more
FAQ
- The following questions and answers provide general information about securities class actions, derivitive litigation, and ERISA class actions. They are not legal advice.
- Securities Class Actions +
- Securities Class Actions and the non-U.S. Investor +
- Shareholder Derivative Actions +
- ERISA 401(k)/Pension Retirement Benefit Class Actions +
Contact Us
- Connecticut
  
  Scott+Scott LLP
  156 South Main Street
  P.O. Box 192
  Colchester, CT 06415
  800.404.7770 toll-free
  860.537.5537 voice
  860.537.4432 fax
- California
  
  Scott+Scott LLP
  600 B Street
  Suite 1500
  San Diego, CA 92101
  800.332-2259 toll-free
  619.233.4565 voice
  619.233.0508 fax
- Ohio
  
  Scott+Scott LLP
  12434 Cedar Road
  Suite 12
  Cleveland Heights, OH 44106
  216.229.6088 voice
  216.229.6092 fax
- New York
  
  Scott+Scott LLP
  500 5th Avenue
  Floor 40
  New York, NY 10110
  800-404-7770 toll-free
  212.223.6444 voice
  212.223.6334 fax
- *Los Angeles Annex Office
  
  Scott+Scott LLP
  6424 Santa Monica Boulevard
  Los Angeles, CA 90038
  213.985.1274, 213.985.1278 (fax)
  
  scottlaw@scott-scott.com
  
  UK Tel: 0808 234 1396
Search
- Go

New Cases

CASES

NutraCea

Class Period: Aug 14, 2007 to Feb 23, 2009

Lead Plaintiff Deadline: Apr 29, 2009 + Deadline passed

Summary of Case:

A securities class action has been fied against NutraCea (Ticker: NTRZ.OB) on behalf of all common stock purchasers from August 14, 2007 though February 23, 2009 (Class Period) in the United States District Court for the District of Arizona. The deadline to file for lead plaintiff is April 29, 2009.

The complaint alleges that Defendants issued materially inaccurate financial statements to the investing public. On February 23, 2009, NutraCea announced that it would be restating revenue for the quarterly periods from the second quarter of 2007 through the fourth quarter of 2008 and for the fiscal year ended December 31, 2007. The restatement is due to NutraCea's improper recognition of revenue on two transactions in 2007. Of the approximately $22.2 million of revenue reported for 2007, NutraCea estimates that $4.6 million will be reversed. News of the pending restatement caused NutraCea's stock price to fall significantly, damaging investors.

If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.